Maria Melander

Principal Research Scientist Servier Symphogen

Seminars

Monday 4th May 2026
Panel Discussion: Building a General Consensus on Model Selection Criteria Across Oncology Drug Development
3:00 pm
  • Understanding the different tumour models used in drug discovery and development across the field
  • Exploring the various questions and contexts of use for each main model type and how translatable and clinically relevant they truly are
  • How did you overcome hurdles encountered with your model when trying to better understand your drug/target?
Maria Melander